These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16298910)

  • 21. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome.
    Brambilla P; Lissau I; Flodmark CE; Moreno LA; Widhalm K; Wabitsch M; Pietrobelli A
    Int J Obes (Lond); 2007 Apr; 31(4):591-600. PubMed ID: 17384660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.
    Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV
    Endothelium; 2007; 14(4-5):193-8. PubMed ID: 17922335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese.
    Xu Y; Li J; Luo Y; Wu Y; Zheng L; Yu J; Ma J; Gu J; Hu D
    Hypertens Res; 2007 Jul; 30(7):613-9. PubMed ID: 17785929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialic acid: a novel marker of cardiovascular disease?
    Gopaul KP; Crook MA
    Clin Biochem; 2006 Jul; 39(7):667-81. PubMed ID: 16624269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
    de Zeeuw D; Bakker SJ
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.
    Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR
    J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic syndrome: should current criteria influence clinical practice?
    Sattar N
    Curr Opin Lipidol; 2006 Aug; 17(4):404-11. PubMed ID: 16832164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to best define the metabolic syndrome.
    Magliano DJ; Shaw JE; Zimmet PZ
    Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic syndrome.
    Domanski M; Proschan M
    J Am Coll Cardiol; 2004 Apr; 43(8):1396-8. PubMed ID: 15093873
    [No Abstract]   [Full Text] [Related]  

  • 39. The mysteries of lipoprotein(a) and cardiovascular disease revisited.
    Kiechl S; Willeit J
    J Am Coll Cardiol; 2010 May; 55(19):2168-70. PubMed ID: 20447544
    [No Abstract]   [Full Text] [Related]  

  • 40. Imaging-based characterization of cardiometabolic phenotypes focusing on whole-body MRI--an approach to disease prevention and personalized treatment.
    Gatidis S; Schlett CL; Notohamiprodjo M; Bamberg F
    Br J Radiol; 2016; 89(1059):20150829. PubMed ID: 26780657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.